[
  {
    "outputFile": "CarePlan-mii-exa-mtb-therapieplan-kombinationstherapie-01.json",
    "fshName": "mii-exa-mtb-therapieplan-kombinationstherapie-01",
    "fshType": "Instance",
    "fshFile": "examples/Therapieempfehlung-Kombinationstherapie-01.fsh",
    "startLine": 41,
    "endLine": 56
  },
  {
    "outputFile": "CarePlan-mii-exa-mtb-therapieplan-kombinationstherapie-02.json",
    "fshName": "mii-exa-mtb-therapieplan-kombinationstherapie-02",
    "fshType": "Instance",
    "fshFile": "examples/Therapieempfehlung-Kombinationstherapie-02.fsh",
    "startLine": 43,
    "endLine": 64
  },
  {
    "outputFile": "CarePlan-mii-exa-mtb-therapieplan-kombinationstherapie-03.json",
    "fshName": "mii-exa-mtb-therapieplan-kombinationstherapie-03",
    "fshType": "Instance",
    "fshFile": "examples/Therapieempfehlung-Kombinationstherapie-03.fsh",
    "startLine": 44,
    "endLine": 59
  },
  {
    "outputFile": "CarePlan-mii-exa-mtb-therapieplan-kombinationstherapie-04.json",
    "fshName": "mii-exa-mtb-therapieplan-kombinationstherapie-04",
    "fshType": "Instance",
    "fshFile": "examples/Therapieempfehlung-Kombinationstherapie-04.fsh",
    "startLine": 38,
    "endLine": 56
  },
  {
    "outputFile": "Claim-BEISPIEL-1.json",
    "fshName": "BEISPIEL-1",
    "fshType": "Instance",
    "fshFile": "profiles/Kostenuebernahme/mii-exa-mtb-antrag-kostenuebernahme-1.fsh",
    "startLine": 1,
    "endLine": 12
  },
  {
    "outputFile": "CodeSystem-mii-cs-mtb-auftrag-begruendung.json",
    "fshName": "MII_CS_MTB_AuftragBegruendung",
    "fshType": "CodeSystem",
    "fshFile": "profiles/Terminologie/AuftragBegruendung.fsh",
    "startLine": 1,
    "endLine": 10
  },
  {
    "outputFile": "CodeSystem-mii-cs-mtb-bestimmungsmethode-tumorzellgehalt.json",
    "fshName": "MII_CS_MTB_BestimmungsmethodeTumorzellgehalt",
    "fshType": "CodeSystem",
    "fshFile": "profiles/Terminologie/BestimmungsmethodeTumorzellgehalt.fsh",
    "startLine": 2,
    "endLine": 8
  },
  {
    "outputFile": "CodeSystem-mii-cs-mtb-therapieempfehlung-evidenzgrad-zusatzverweis.json",
    "fshName": "MII_CS_MTB_TherapieempfehlungEvidenzgradZusatzverweis",
    "fshType": "CodeSystem",
    "fshFile": "profiles/Terminologie/Evidenzgraduierung.fsh",
    "startLine": 52,
    "endLine": 73
  },
  {
    "outputFile": "CodeSystem-mii-cs-mtb-therapieempfehlung-evidenzgrad.json",
    "fshName": "MII_CS_MTB_TherapieempfehlungEvidenzgrad",
    "fshType": "CodeSystem",
    "fshFile": "profiles/Terminologie/Evidenzgraduierung.fsh",
    "startLine": 1,
    "endLine": 42
  },
  {
    "outputFile": "CodeSystem-mii-cs-mtb-therapieempfehlung-status-begruendung.json",
    "fshName": "MII_CS_MTB_TherapieempfehlungStatusBegruendung",
    "fshType": "CodeSystem",
    "fshFile": "profiles/Terminologie/TherapieempfehlungStatusBegruendung.fsh",
    "startLine": 1,
    "endLine": 6
  },
  {
    "outputFile": "Medication-mii-exa-mtb-kombinationstherapie-01.json",
    "fshName": "mii-exa-mtb-kombinationstherapie-01",
    "fshType": "Instance",
    "fshFile": "examples/Therapieempfehlung-Kombinationstherapie-01.fsh",
    "startLine": 77,
    "endLine": 107
  },
  {
    "outputFile": "Medication-mii-exa-mtb-kombinationstherapie-02-dabrafenib.json",
    "fshName": "mii-exa-mtb-kombinationstherapie-02-dabrafenib",
    "fshType": "Instance",
    "fshFile": "examples/Therapieempfehlung-Kombinationstherapie-02.fsh",
    "startLine": 85,
    "endLine": 102
  },
  {
    "outputFile": "Medication-mii-exa-mtb-kombinationstherapie-02-trametinib.json",
    "fshName": "mii-exa-mtb-kombinationstherapie-02-trametinib",
    "fshType": "Instance",
    "fshFile": "examples/Therapieempfehlung-Kombinationstherapie-02.fsh",
    "startLine": 122,
    "endLine": 139
  },
  {
    "outputFile": "Medication-mii-exa-mtb-kombinationstherapie-03-dabrafenib.json",
    "fshName": "mii-exa-mtb-kombinationstherapie-03-dabrafenib",
    "fshType": "Instance",
    "fshFile": "examples/Therapieempfehlung-Kombinationstherapie-03.fsh",
    "startLine": 87,
    "endLine": 104
  },
  {
    "outputFile": "Medication-mii-exa-mtb-kombinationstherapie-03-trametinib.json",
    "fshName": "mii-exa-mtb-kombinationstherapie-03-trametinib",
    "fshType": "Instance",
    "fshFile": "examples/Therapieempfehlung-Kombinationstherapie-03.fsh",
    "startLine": 110,
    "endLine": 127
  },
  {
    "outputFile": "Medication-mii-exa-mtb-kombinationstherapie-03.json",
    "fshName": "mii-exa-mtb-kombinationstherapie-03",
    "fshType": "Instance",
    "fshFile": "examples/Therapieempfehlung-Kombinationstherapie-03.fsh",
    "startLine": 75,
    "endLine": 85
  },
  {
    "outputFile": "Medication-mii-exa-mtb-medikation-04-dabrafenib.json",
    "fshName": "mii-exa-mtb-medikation-04-dabrafenib",
    "fshType": "Instance",
    "fshFile": "examples/Therapieempfehlung-Kombinationstherapie-04.fsh",
    "startLine": 107,
    "endLine": 124
  },
  {
    "outputFile": "Medication-mii-exa-mtb-medikation-04-trametinib.json",
    "fshName": "mii-exa-mtb-medikation-04-trametinib",
    "fshType": "Instance",
    "fshFile": "examples/Therapieempfehlung-Kombinationstherapie-04.fsh",
    "startLine": 126,
    "endLine": 143
  },
  {
    "outputFile": "MedicationRequest-mii-exa-mtb-therapieempfehlung-02-dabrafenib.json",
    "fshName": "mii-exa-mtb-therapieempfehlung-02-dabrafenib",
    "fshType": "Instance",
    "fshFile": "examples/Therapieempfehlung-Kombinationstherapie-02.fsh",
    "startLine": 66,
    "endLine": 83
  },
  {
    "outputFile": "MedicationRequest-mii-exa-mtb-therapieempfehlung-02-trametinib.json",
    "fshName": "mii-exa-mtb-therapieempfehlung-02-trametinib",
    "fshType": "Instance",
    "fshFile": "examples/Therapieempfehlung-Kombinationstherapie-02.fsh",
    "startLine": 104,
    "endLine": 120
  },
  {
    "outputFile": "MedicationRequest-mii-exa-mtb-therapieempfehlung-04-dabrafenib.json",
    "fshName": "mii-exa-mtb-therapieempfehlung-04-dabrafenib",
    "fshType": "Instance",
    "fshFile": "examples/Therapieempfehlung-Kombinationstherapie-04.fsh",
    "startLine": 75,
    "endLine": 89
  },
  {
    "outputFile": "MedicationRequest-mii-exa-mtb-therapieempfehlung-04-trametinib.json",
    "fshName": "mii-exa-mtb-therapieempfehlung-04-trametinib",
    "fshType": "Instance",
    "fshFile": "examples/Therapieempfehlung-Kombinationstherapie-04.fsh",
    "startLine": 91,
    "endLine": 105
  },
  {
    "outputFile": "MedicationRequest-mii-exa-mtb-therapieempfehlung-kombinationstherapie-01.json",
    "fshName": "mii-exa-mtb-therapieempfehlung-kombinationstherapie-01",
    "fshType": "Instance",
    "fshFile": "examples/Therapieempfehlung-Kombinationstherapie-01.fsh",
    "startLine": 58,
    "endLine": 72
  },
  {
    "outputFile": "MedicationRequest-mii-exa-mtb-therapieempfehlung-kombinationstherapie-03.json",
    "fshName": "mii-exa-mtb-therapieempfehlung-kombinationstherapie-03",
    "fshType": "Instance",
    "fshFile": "examples/Therapieempfehlung-Kombinationstherapie-03.fsh",
    "startLine": 61,
    "endLine": 73
  },
  {
    "outputFile": "NamingSystem-mii-ns-mtb-nct.json",
    "fshName": "mii-ns-mtb-nct",
    "fshType": "Instance",
    "fshFile": "NamingSystems.fsh",
    "startLine": 6,
    "endLine": 17
  },
  {
    "outputFile": "NamingSystem-mii-ns-studie-drks.json",
    "fshName": "mii-ns-studie-drks",
    "fshType": "Instance",
    "fshFile": "NamingSystems.fsh",
    "startLine": 20,
    "endLine": 31
  },
  {
    "outputFile": "NamingSystem-mii-ns-studie-eudract.json",
    "fshName": "mii-ns-studie-eudract",
    "fshType": "Instance",
    "fshFile": "NamingSystems.fsh",
    "startLine": 34,
    "endLine": 45
  },
  {
    "outputFile": "Patient-mii-exa-mtb-patient-01.json",
    "fshName": "mii-exa-mtb-patient-01",
    "fshType": "Instance",
    "fshFile": "examples/Therapieempfehlung-Kombinationstherapie-01.fsh",
    "startLine": 34,
    "endLine": 39
  },
  {
    "outputFile": "Patient-mii-exa-mtb-patient-02.json",
    "fshName": "mii-exa-mtb-patient-02",
    "fshType": "Instance",
    "fshFile": "examples/Therapieempfehlung-Kombinationstherapie-02.fsh",
    "startLine": 36,
    "endLine": 41
  },
  {
    "outputFile": "Patient-mii-exa-mtb-patient-03.json",
    "fshName": "mii-exa-mtb-patient-03",
    "fshType": "Instance",
    "fshFile": "examples/Therapieempfehlung-Kombinationstherapie-03.fsh",
    "startLine": 37,
    "endLine": 42
  },
  {
    "outputFile": "Patient-mii-exa-mtb-patient-04.json",
    "fshName": "mii-exa-mtb-patient-04",
    "fshType": "Instance",
    "fshFile": "examples/Therapieempfehlung-Kombinationstherapie-04.fsh",
    "startLine": 31,
    "endLine": 36
  },
  {
    "outputFile": "RequestGroup-mii-exa-mtb-therapieempfehlung-kombinationstherapie-04.json",
    "fshName": "mii-exa-mtb-therapieempfehlung-kombinationstherapie-04",
    "fshType": "Instance",
    "fshFile": "examples/Therapieempfehlung-Kombinationstherapie-04.fsh",
    "startLine": 58,
    "endLine": 73
  },
  {
    "outputFile": "StructureDefinition-mii-ex-mtb-diagnose.json",
    "fshName": "MII_EX_MTB_Diagnose",
    "fshType": "Extension",
    "fshFile": "profiles/Beschluss-Therapieplan/Studieneinschluss-Anfrage.fsh",
    "startLine": 49,
    "endLine": 55
  },
  {
    "outputFile": "StructureDefinition-mii-ex-mtb-therapieempfehlung-evidenzgraduierung-publikation.json",
    "fshName": "MII_EX_MTB_Therapieempfehlung_Evidenzgraduierung_Publikation",
    "fshType": "Extension",
    "fshFile": "profiles/Beschluss-Therapieplan/Therapieempfehlung-Evidenzgraduierung-Publikation.fsh",
    "startLine": 1,
    "endLine": 7
  },
  {
    "outputFile": "StructureDefinition-mii-ex-mtb-therapieempfehlung-evidenzgraduierung.json",
    "fshName": "MII_EX_MTB_Therapieempfehlung_Evidenzgraduierung",
    "fshType": "Extension",
    "fshFile": "profiles/Beschluss-Therapieplan/Therapieempfehlung-Evidenzgraduierung.fsh",
    "startLine": 1,
    "endLine": 26
  },
  {
    "outputFile": "StructureDefinition-mii-ex-mtb-therapieempfehlung-prioritaet.json",
    "fshName": "MII_EX_MTB_Therapieempfehlung_Prioritaet",
    "fshType": "Extension",
    "fshFile": "profiles/Beschluss-Therapieplan/Therapieempfehlung-Prioritaet.fsh",
    "startLine": 1,
    "endLine": 7
  },
  {
    "outputFile": "StructureDefinition-mii-lm-mtb.json",
    "fshName": "MII_LM_MTB",
    "fshType": "Logical",
    "fshFile": "logical-model/Molekulares-Tumorboard.fsh",
    "startLine": 1,
    "endLine": 8
  },
  {
    "outputFile": "StructureDefinition-mii-pr-mtb-antrag-kostenuebernahme.json",
    "fshName": "MII_PR_MTB_ANTRAG_KOSTENUEBERNAHME",
    "fshType": "Profile",
    "fshFile": "profiles/Kostenuebernahme/mii-pr-mtb-antrag-kostenuebernahme.fsh",
    "startLine": 1,
    "endLine": 32
  },
  {
    "outputFile": "StructureDefinition-mii-pr-mtb-antwort-kostenuebernahme.json",
    "fshName": "MII_PR_MTB_ANTWORT_KOSTENUEBERNAHME",
    "fshType": "Profile",
    "fshFile": "profiles/Kostenuebernahme/mii-pr-mtb-antwort-kostenuebernahme.fsh",
    "startLine": 1,
    "endLine": 27
  },
  {
    "outputFile": "StructureDefinition-mii-pr-mtb-biopsie-auftrag.json",
    "fshName": "MII_PR_MTB_Biopsie_Auftrag",
    "fshType": "Profile",
    "fshFile": "profiles/Beschluss-Therapieplan/Rebiopsie-Auftrag.fsh",
    "startLine": 1,
    "endLine": 30
  },
  {
    "outputFile": "StructureDefinition-mii-pr-mtb-histologie-evaluation-auftrag.json",
    "fshName": "MII_PR_MTB_Histologie_Evaluation_Auftrag",
    "fshType": "Profile",
    "fshFile": "profiles/Beschluss-Therapieplan/Histologie-Reevaluation-Auftrag.fsh",
    "startLine": 1,
    "endLine": 30
  },
  {
    "outputFile": "StructureDefinition-mii-pr-mtb-humangenetische-beratung-auftrag.json",
    "fshName": "MII_PR_MTB_Humangenetische_Beratung_Auftrag",
    "fshType": "Profile",
    "fshFile": "profiles/Beschluss-Therapieplan/Humangenetische-Beratung-Auftrag.fsh",
    "startLine": 1,
    "endLine": 12
  },
  {
    "outputFile": "StructureDefinition-mii-pr-mtb-studie.json",
    "fshName": "MII_PR_MTB_Studie",
    "fshType": "Profile",
    "fshFile": "profiles/Beschluss-Therapieplan/Studieneinschluss-Anfrage.fsh",
    "startLine": 19,
    "endLine": 46
  },
  {
    "outputFile": "StructureDefinition-mii-pr-mtb-studieneinschluss-anfrage.json",
    "fshName": "MII_PR_MTB_Studieneinschluss_Anfrage",
    "fshType": "Profile",
    "fshFile": "profiles/Beschluss-Therapieplan/Studieneinschluss-Anfrage.fsh",
    "startLine": 1,
    "endLine": 16
  },
  {
    "outputFile": "StructureDefinition-mii-pr-mtb-therapieempfehlung-gruppe.json",
    "fshName": "MII_PR_MTB_Therapieempfehlung_Gruppe",
    "fshType": "Profile",
    "fshFile": "profiles/Beschluss-Therapieplan/Kombinationstherapie-Empfehlung.fsh",
    "startLine": 1,
    "endLine": 42
  },
  {
    "outputFile": "StructureDefinition-mii-pr-mtb-therapieempfehlung.json",
    "fshName": "MII_PR_MTB_Therapieempfehlung",
    "fshType": "Profile",
    "fshFile": "profiles/Beschluss-Therapieplan/Therapieempfehlung.fsh",
    "startLine": 1,
    "endLine": 41
  },
  {
    "outputFile": "StructureDefinition-mii-pr-mtb-therapieplan.json",
    "fshName": "MII_PR_MTB_Therapieplan",
    "fshType": "Profile",
    "fshFile": "profiles/Beschluss-Therapieplan/Therapieplan.fsh",
    "startLine": 1,
    "endLine": 53
  },
  {
    "outputFile": "StructureDefinition-mii-pr-mtb-tumorzellgehalt.json",
    "fshName": "MII_PR_MTB_Tumorzellgehalt",
    "fshType": "Profile",
    "fshFile": "profiles/Beschluss-Therapieplan/Tumorzellgehalt.fsh",
    "startLine": 1,
    "endLine": 23
  },
  {
    "outputFile": "ValueSet-mii-vs-mtb-antrag-kostenuebernahme.json",
    "fshName": "MII_VS_MTB_ANTRAG_KOSTENUEBERNAHME",
    "fshType": "ValueSet",
    "fshFile": "profiles/Kostenuebernahme/mii-vs-mtb-antrag-kostenuebernahme-type.fsh",
    "startLine": 1,
    "endLine": 8
  },
  {
    "outputFile": "ValueSet-mii-vs-mtb-auftrag-begruendung.json",
    "fshName": "MII_VS_MTB_AuftragBegruendung",
    "fshType": "ValueSet",
    "fshFile": "profiles/Terminologie/AuftragBegruendung.fsh",
    "startLine": 12,
    "endLine": 17
  },
  {
    "outputFile": "ValueSet-mii-vs-mtb-bestimmungsmethode-tumorzellgehalt.json",
    "fshName": "MII_VS_MTB_BestimmungsmethodeTumorzellgehalt",
    "fshType": "ValueSet",
    "fshFile": "profiles/Terminologie/BestimmungsmethodeTumorzellgehalt.fsh",
    "startLine": 10,
    "endLine": 15
  },
  {
    "outputFile": "ValueSet-mii-vs-mtb-therapieempfehlung-evidenzgrad-zusatzverweis.json",
    "fshName": "MII_VS_MTB_Therapieempfehlung_EvidenzgradZusatzverweis",
    "fshType": "ValueSet",
    "fshFile": "profiles/Terminologie/Evidenzgraduierung.fsh",
    "startLine": 75,
    "endLine": 81
  },
  {
    "outputFile": "ValueSet-mii-vs-mtb-therapieempfehlung-evidenzgrad.json",
    "fshName": "MII_VS_MTB_Therapieempfehlung_Evidenzgrad",
    "fshType": "ValueSet",
    "fshFile": "profiles/Terminologie/Evidenzgraduierung.fsh",
    "startLine": 44,
    "endLine": 50
  },
  {
    "outputFile": "ValueSet-mii-vs-mtb-therapieempfehlung-status-begruendung.json",
    "fshName": "MII_VS_MTB_TherapieempfehlungStatusBegruendung",
    "fshType": "ValueSet",
    "fshFile": "profiles/Terminologie/TherapieempfehlungStatusBegruendung.fsh",
    "startLine": 8,
    "endLine": 13
  }
]
